Skip Navigation

Cardiovascular Research 2002 54(2):427-437; doi:10.1016/S0008-6363(02)00260-2
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thijssen, V. L.J.L
Right arrow Articles by Jongsma, H. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thijssen, V. L.J.L
Right arrow Articles by Jongsma, H. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Analysis of altered gene expression during sustained atrial fibrillation in the goat

Victor L.J.L Thijssena,*,1, Huub M.W van der Veldenb,1, Erwin P van Ankerenb, Jannie Ausmac, Maurits A Allessiec, Marcel Borgersa, Guillaume J.J.M van Eysd and Habo J Jongsmab

aDepartment of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands
bDepartment of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands
cDepartment of Physiology, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands
dDepartment of Molecular Genetics, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands

Victor.Thijssen{at}Molcelb.Unimaas.nl

* Corresponding author. Tel.: +31-43-388-1361; fax: +31-43-388-4151

Objective: Atrial fibrillation (AF) is characterised by electrical, gap junctional and structural remodelling. However, the underlying molecular mechanisms of these phenomena are largely unknown. To get more insight into atrial remodelling at the molecular level we have analysed changes in gene expression during sustained AF in the goat. Methods: The differential display technique (DD) was used to identify genes differentially expressed during sustained AF (13.9±5.2 weeks) as compared to sinus rhythm (SR). Dot-blot analysis was performed to confirm the altered gene expression and to establish the changes in expression after 1, 2, 4, 8 and 16 weeks of AF. Immunohistochemistry and western blotting were used to validate the DD approach and to further characterise the changed expression of the β-myosin heavy chain gene at the protein level. Results: Of the approximately 125 fragments that showed changed expression levels during AF, 34 were cloned and sequenced. Twenty-one of these represented known genes involved in cardiomyocyte structure, metabolism, expression regulation, or differentiation status. The changed expression of 70% of the isolated clones could be confirmed by dot-blot analysis. In addition, time course analysis revealed different profiles of expression as well as transient re-expression of genes, e.g. the gene for hypoxia-inducible factor 1{alpha} during the first week of AF. During sustained AF the frequency of cardiomyocytes expressing β myosin heavy chain (βMHC) increased from 21.8±2.1 to 47.9±2.5% (S.E.M.). The overall expression of MHC ({alpha}+β) appeared to be down-regulated during AF. Conclusions: AF is accompanied by changes in expression of proteins involved in cellular structure, metabolism, gene expression regulation and (de-)differentiation. Most alterations in expression confirm or support the hypothesis of cardiomyocyte de-differentiation. Furthermore, the results suggest a role for ischemic stress in the early response of cardiomyocytes to AF, possibly via activation of hypoxia-inducible factor 1{alpha}.

KEYWORDS Arrhythmia (mechanisms); Atrial function; Remodeling; Gene expression; Ischemia; Myocytes


1 Both authors contributed equally to this manuscript.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S.-M. Chaldoupi, P. Loh, R. N.W. Hauer, J. M.T. de Bakker, and H. V.M. van Rijen
The role of connexin40 in atrial fibrillation
Cardiovasc Res, July 7, 2009; (2009) cvp203v2.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Ausma and M. Borgers
Dedifferentiation of atrial cardiomyocytes: from in vivo to in vitro
Cardiovasc Res, July 1, 2002; 55(1): 9 - 12.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel, M. Allessie, and M. Haissaguerre
Spotlight on atrial fibrillation--the 'complete arrhythmia'
Cardiovasc Res, May 1, 2002; 54(2): 197 - 203.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.